Pestalozzi advised Adragos Pharma on the deal, while Kellerhals Carrard advised the seller. Adragos Pharma, a global pharmaceutical contract development and manufacturing organization (CDMO) headquartered in...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here